Browsing Tag
The Lancet Infectious Diseases
1 post
CSL Seqirus reports stronger immune response with enhanced flu vaccine in adults over 50
CSL Seqirus has published pivotal Phase III results from 7,699 adults showing superior immune responses versus an adjuvanted egg-based flu vaccine, while the study design leaves real-world comparative effectiveness as a separate question.